Bergaptol, a Major Furocoumarin in Citrus: Pharmacological Properties and Toxicity
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Bergaptol, a natural compound from citrus fruits, shows diverse pharmacological benefits including anti-cancer and antioxidant effects. Further research is needed to confirm its safety and efficacy in humans.
Area Of Science
- Pharmacology
- Natural Products Chemistry
- Toxicology
Background
- Bergaptol (5-hydroxypsoralen) is a furanocoumarin found in citrus fruits with potential health benefits.
- No comprehensive reviews on bergaptol's pharmacology and toxicity exist.
- Understanding bergaptol is crucial for future research and applications.
Purpose Of The Study
- To review existing research on the pharmacological properties of bergaptol.
- To investigate the toxicity profile of bergaptol.
- To guide future research and applications of bergaptol.
Main Methods
- Literature review of scientific evidence on bergaptol.
- Analysis of in vitro and in vivo studies.
- Examination of pharmacological effects and toxicity data.
Main Results
- Bergaptol exhibits anti-inflammatory, antioxidant, anti-cancer, anti-osteoporosis, antimicrobial, and anti-lipidemic effects.
- It inhibits cytochrome P450 enzymes (CYP2C9, CYP3A4) and drug efflux transporters like P-glycoprotein, potentially overcoming drug resistance.
- Unlike most furocoumarins, bergaptol is not phototoxic or photomutagenic in vitro; its in vivo toxicity requires further investigation.
Conclusions
- Bergaptol possesses significant pharmacological potential for various health applications.
- Its ability to modulate drug metabolism and overcome resistance warrants further study.
- More in vivo and clinical research is essential to establish safe and effective dosages for bergaptol.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...